Research and Markets: Global Gastric Cancer Pipeline Report 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/f6sq7l/gastric_cancer) has announced the addition of the "Gastric Cancer - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Gastric Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastric Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Gastric Cancer Overview
  3. Therapeutics Development
  4. Gastric Cancer - Therapeutics under Development by Companies
  5. Gastric Cancer - Therapeutics under Investigation by Universities/Institutes
  6. Gastric Cancer - Pipeline Products Glance
  7. Gastric Cancer - Products under Development by Companies
  8. Gastric Cancer - Products under Investigation by Universities/Institutes
  9. Gastric Cancer - Companies Involved in Therapeutics Development
  10. Gastric Cancer - Therapeutics Assessment
  11. Drug Profiles
  12. Gastric Cancer - Recent Pipeline Updates
  13. Gastric Cancer - Dormant Projects
  14. Gastric Cancer - Discontinued Products
  15. Gastric Cancer - Product Development Milestones
  16. Appendix

Companies Mentioned: Partial List

- AB Science

- Chipscreen Biosciences Ltd

- Chugai Pharmaceutical Co., Ltd.

- Covagen AG

- DAE HWA Pharmaceutical Co., Ltd.

- Daiichi Sankyo Company, Limited

- Galena Biopharma, Inc.

- Genentech, Inc.

- GlaxoSmithKline plc

- GlycoNex Inc.

- Glycotope GmbH

- ISU ABXIS Co.,Ltd.

- Jiangsu Hengrui Medicine Co., Ltd.

- Jiangsu Kanion Pharmaceutical Co., Ltd.

- Kadmon Corporation, LLC

- Millennium Pharmaceuticals, Inc.

- Molecular Targeting Technologies, Inc.

- MSM Protein Technologies, Inc.

- NanoCarrier Co., Ltd.

- NeoPharm Co., Ltd.

- Novartis AG

- Regulon Inc.

- Rexahn Pharmaceuticals, Inc.

- Richter Gedeon Nyrt.

- Sanofi

- Sareum Holdings plc

- SentoClone International AB

- Sequella, Inc.

- Zymeworks Inc.

For more information visit http://www.researchandmarkets.com/research/f6sq7l/gastric_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology